113 related articles for article (PubMed ID: 9224786)
1. Characterization of the novel benzisothiazole ring-cleaved products of the antipsychotic drug ziprasidone.
Prakash C; Kamel A; Cui D
Drug Metab Dispos; 1997 Jul; 25(7):897-901. PubMed ID: 9224786
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
4. Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry.
Li P; Wang GJ; Li J; Hao HP; Zheng CN
J Mass Spectrom; 2006 May; 41(5):670-84. PubMed ID: 16598708
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
Mutlib AE; Jurcak J; Hrib N
Drug Metab Dispos; 1996 Oct; 24(10):1139-50. PubMed ID: 8894517
[TBL] [Abstract][Full Text] [Related]
6. Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone.
Mutlib AE; Strupczewski JT; Chesson SM
Drug Metab Dispos; 1995 Sep; 23(9):951-64. PubMed ID: 8565786
[TBL] [Abstract][Full Text] [Related]
7. Characterization of imatinib metabolites in rat and human liver microsomes: differentiation of hydroxylation from N-oxidation by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
Ma S; Xu Y; Shou M
Rapid Commun Mass Spectrom; 2009 May; 23(10):1446-50. PubMed ID: 19353558
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
10. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
[TBL] [Abstract][Full Text] [Related]
11. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
Bu HZ; Poglod M; Micetich RG; Khan JK
J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of MK-0767 and seven metabolites in rat urine using liquid chromatography/tandem mass spectrometry.
Shen Z; Kochansky C; Bakhtiar R; Franklin RB; Vincent SH
Rapid Commun Mass Spectrom; 2004; 18(18):2113-20. PubMed ID: 15317046
[TBL] [Abstract][Full Text] [Related]
13. Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry.
Luffer-Atlas D; Vincent SH; Painter SK; Arison BH; Stearns RA; Chiu SH
Drug Metab Dispos; 1997 Aug; 25(8):940-52. PubMed ID: 9280402
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
Aprile S; Del Grosso E; Tron GC; Grosa G
Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the antipsychotic drug tiospirone in humans.
Mayol RF; Jajoo HK; Klunk LJ; Blair IA
Drug Metab Dispos; 1991; 19(2):394-9. PubMed ID: 1676643
[TBL] [Abstract][Full Text] [Related]
16. Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centers.
Greene RJ; Davis JA; Subramanian R; Deane MR; Emery MG; Slatter JG
Drug Metab Dispos; 2012 May; 40(5):928-42. PubMed ID: 22328582
[TBL] [Abstract][Full Text] [Related]
17. Characterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS.
Mutlib AE; Chui YC; Young LM; Abbott FS
Drug Metab Dispos; 1992; 20(6):840-8. PubMed ID: 1362936
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of a dopamine receptor partial agonist in rats, including an unusual N-dearylation reaction.
Zhao SX; Wang WW; Walker GS; Zhang L; Obach RS
Drug Metab Pharmacokinet; 2011 Jun; 26(3):266-79. PubMed ID: 21383524
[TBL] [Abstract][Full Text] [Related]
19. Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: application to studies on the biotransformation of indinavir.
Anari MR; Sanchez RI; Bakhtiar R; Franklin RB; Baillie TA
Anal Chem; 2004 Feb; 76(3):823-32. PubMed ID: 14750881
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]